XBiotech Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -121.3% | – | – | – | |
| – | -17.1% | -15.3% | +5.3% | -0.1% | +112.6% | +63.9% | -3.0% | -5.2% | +18.3% | -1.3% | -33.3% | +0.1% | -3.4% | |
| – | -73.8% | +849.9% | -37.2% | +26.5% | -68.6% | -5.1% | +102.3% | +274.7% | -64.5% | +13.4% | -35.6% | -46.3% | +106.6% | |
| – | – | – | -39.5% | +31.1% | -68.6% | -5.1% | +75.5% | +328.7% | -64.3% | +76.2% | – | – | – | |
| – | – | – | -133.1% | – | -970.3% | – | -3,568.1% | – | – | -90.5% | -64.2% | -153.7% | – | |
| – | -89.3% | +2,267.8% | +643.9% | +33.9% | -89.9% | -91.3% | +67.2% | +1,727.0% | -5.4% | -83.4% | -38.1% | +260.2% | -77.8% | |
| – | -89.3% | +2,267.8% | +643.9% | +33.9% | -89.9% | -91.3% | – | -100.6% | -5.4% | +1,712.5% | – | -102.1% | -77.8% | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | |
| – | – | – | +21.3% | -96.2% | +1,031.9% | -99.4% | +20,693.0% | -1,104.9% | – | – | – | – | – | |
| – | – | – | +0.0% | – | – | – | – | – | – | – | – | – | -200.0% | |
| – | +65.4% | +424.7% | +22.6% | -96.2% | +1,031.9% | -99.4% | +20,843.3% | -1,073.3% | -83.6% | – | -127.3% | – | -198.1% | |
| – | – | +1,527.7% | -32.7% | -268.2% | – | – | – | -168.3% | – | – | – | -164.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -123.4% | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.